Compare ICICI Prudential Nifty Pharma Index Fund vs Mirae Asset Healthcare Fund
Risk
Very High
Very High
Rating
2.0
3.0
Min SIP Amount
₹1000
₹99
Expense Ratio
1.05
2.04
NAV
₹17.61
₹40.14
Fund Started
25 Nov 2022
11 Jun 2018
Fund Size
₹104.67 Cr
₹2753.72 Cr
Exit Load
-
Exit load of 1% if redeemed within 1 year.
1 Year
6.43%
9.40%
3 Year
21.60%
23.81%
5 Year
-
14.41%
Equity
99.86%
99.92%
Cash
0.14%
0.08%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 22.89% |
Dr. Reddy's Laboratories Ltd. | 9.41% |
Divi's Laboratories Ltd. | 9.30% |
Cipla Ltd. | 8.47% |
Lupin Ltd. | 6.90% |
Torrent Pharmaceuticals Ltd. | 5.43% |
Laurus Labs Ltd. | 4.75% |
Aurobindo Pharma Ltd. | 4.49% |
Glenmark Pharmaceuticals Ltd. | 3.95% |
Alkem Laboratories Ltd. | 3.81% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Divi's Laboratories Ltd. | 7.93% |
Glenmark Pharmaceuticals Ltd. | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. | 6.88% |
Apollo Hospitals Enterprise Ltd. | 6.15% |
Lupin Ltd. | 5.06% |
Aurobindo Pharma Ltd. | 4.32% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Fortis Healthcare Ltd. | 3.73% |
Laurus Labs Ltd. | 3.56% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Launch Date
25 Nov 2022
11 Jun 2018
